PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

AHFS Consumer Medication Information [Internet]. Bethesda (MD): American Society of Health-System Pharmacists; 2000-2011.

AHFS Consumer Medication Information.

Vincristine(vin kris' teen)

Last reviewed: September 1, 2010.

Warning

Vincristine when administered into a vein may leak into surrounding tissue. Your doctor or nurse will monitor your administration site for this reaction.

About your treatment

Your doctor has ordered the drug vincristine to help treat your illness. The drug is given by injection into a vein.

This medication is used to treat:

  • leukemia

  • Hodgkin's disease

  • non-Hodgkin's lymphomas

  • neuroblastoma

  • rhabdomyosarcoma

  • Wilms' tumor

  • Kaposi's sarcoma related to acquired immunodeficiency syndrome (AIDS)

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Vincristine is in a class of drugs known as vinca alkaloids. It slows or stops the growth of cancer cells in your body. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

Other uses for this medicine

Vincristine is also used to treat some types of sarcoma, small cell lung cancer, osteogenic sarcoma, Ewing's sarcoma, Burkitt's lymphoma, brain medulloblastoma, multiple myeloma, idiopathic thrombocytopenia purpura, and autoimmune hemolytic anemia. Talk to your doctor about the possible risks of using this drug for your condition.

What special precautions should I follow?

Before taking vincristine,

  • tell your doctor and pharmacist if you are allergic to vincristine or any other drugs.

  • tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially aspirin, itraconazole (Sporanox), and vitamins.

  • tell your doctor if you have or have ever had heart, liver, nerve, or muscle disease.

  • tell your doctor if you are currently receiving radiation therapy.

  • you should know that vincristine may interfere with the normal menstrual cycle (period) in women and may stop sperm production in men. However, you should not assume that you cannot get pregnant or that you cannot get someone else pregnant. Women who are pregnant or breast-feeding should tell their doctors before they begin taking this drug. You should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy. Vincristine may harm the fetus.

  • do not have any vaccinations (e.g., measles or flu shots) without talking to your doctor.

What side effects can this medication cause?

Side effects from vincristine are common and include:

  • nausea and vomiting

  • stomach pain and cramps

  • constipation

  • diarrhea

  • jaw pain, headache, or other aches

  • thinned or brittle hair

Tell your doctor if either of these symptoms is severe or lasts for several hours:

  • fatigue

  • mouth blistering

If you experience any of the following symptoms, call your doctor immediately:

  • tingling, numbness, and cramping in the legs or arms for longer than a few days

  • severe abdominal or muscle cramping

  • difficulty walking

  • hoarseness

  • vision problems

  • change in normal bowel habits for more than 2 days

  • sore throat

  • swelling of the feet and ankles

  • difficulty controlling bladder

  • increased, painful, or difficult urination

  • redness, pain, or swelling at the injection site

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/Safety/MedWatch] or by phone [1-800-332-1088].

In case of emergency/overdose

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Special instructions

  • A common side effect of vincristine is a decrease of blood cells. Your doctor may order tests before, during, and after your treatment to see if your blood cells are affected by the drug.

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.

The American Society of Health-System Pharmacists, Inc. represents that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. makes no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS® Consumer Medication Information. © Copyright, 2011. The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.

The following brand names are from RxNorm, a standardized nomenclature for clinical drugs produced by the National Library of Medicine:

Brand names

  • Oncovin

  • Vincasar

What works?

  • Comparison of the two international standards of chemotherapy for patients with early unfavourable or advanced stage Hodgkin lymphoma Comparison of the two international standards of chemotherapy for patients with early unfavourable or advanced stage Hodgkin lymphoma
    Hodgkin lymphoma is a malignancy of the lymphatic system. It is one of the most common cancers in young adults, particularly in their third decade of life, but it occurs also in children and elderly people. Within the last fifty years it has become one of the most curable forms of cancer. To find the best treatment with the greatest efficacy and least toxicity is the most important challenge in treating Hodgkin lymphoma. There are two international standards for the treatment of early unfavourable or advanced stage Hodgkin lymphoma: chemotherapy with escalated BEACOPP (bleomycin/etoposide/doxorubicin/cyclophosphamide/vincristine/procarbazine/prednisone) regimen initiated by the German Hodgkin Study Group (GHSG) and chemotherapy with ABVD (doxorubicin/ bleomycin/ vinblastine/ dacarbazine) regimen, which is widely used because it has been proven to be effective, well tolerated and easy to administer. We aimed to clarify the advantages and disadvantages of both treatments by comparing the chance of survival (overall survival), the chance of recurrence of the tumour and the frequencies of adverse events after treatment in patients with early unfavourable stage or advanced stage Hodgkin lymphoma.
See all (6)...

In the news

  • Image for UK NHS headline Clot risk of contraceptive patch examined
    11 May 2012
    “Women using a vaginal ring or skin patch for contraception are at around double the risk of a blood clot compared to those taking the Pill,” says the Daily Mail. The news is based on a large Danish ...
more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...